Pathogenic bacterial profile and drug resistance analysis of community-acquired pneumonia in older outpatients with fever

Journal of International Medical Research

Volumn 46, Issue 11, 2018, Pages 4596-4604

  Luan, Ying ^a   Sun, Yuling ^a   Duan, Shuhong ^a   Zhao, Ping ^a   Bao, Zhongying ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Antibiotics; Community acquired pneumonia; Drug sensitivity; Infection; Older people; Pathogenic bacteria

Indexed keywords

AMIKACIN; AMPICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; AZTREONAM; CEFEPIME; CEFOPERAZONE; CEFOPERAZONE PLUS SULBACTAM; CEFOTAXIME; CEFTAZIDIME; CEFUROXIME; CIPROFLOXACIN; CLINDAMYCIN; CORTICOSTEROID; ERYTHROMYCIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; LINEZOLID; MINOCYCLINE; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; TEICOPLANIN; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CHINA; CLINICAL OUTCOME; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; ESCHERICHIA COLI; EVIDENCE BASED MEDICINE; FEMALE; FEVER; HUMAN; HUMAN CELL; INFECTION RISK; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; NONHUMAN; OUTCOME ASSESSMENT; OUTPATIENT; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SPUTUM EXAMINATION; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; COMMUNITY ACQUIRED INFECTION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; MULTIVARIATE ANALYSIS; PNEUMONIA; TREATMENT OUTCOME;

AGED; COMMUNITY-ACQUIRED INFECTIONS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; FEVER; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MULTIVARIATE ANALYSIS; OUTPATIENTS; PNEUMONIA; RISK FACTORS; TREATMENT OUTCOME;

EID: 85056280782     PISSN: 03000605     EISSN: 14732300     Source Type: Journal    
DOI: 10.1177/0300060518786915     Document Type: Article

References (25)

1. Lozano, R, Naghavi, M, Foreman, K. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2013; 380: 2095-2128.
2. Lim, WS, Baudouin, SV, George, RC. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 2009; 64(Suppl 3): iii1-iii55.
3. Jokinen, C, Heiskanen, L, Juvonen, H. Incidence of community-acquired pneumonia in the population of four municipalities in eastern Finland. Am J Epidemiol 1993; 137: 977-988.
4. Myint, PK, Kwok, CS, Majumdar, SR. The International Community-Acquired Pneumonia (CAP) Collaboration Cohort (ICCC) study: rationale, design and description of study cohorts and patients. BMJ Open 2012; 2: e001030.
5. Jain, S, Self, WH, Wunderink, RG. Community-acquired pneumonia requiring hospitalization among U.S. adults. N Engl J Med 2015; 373: 415-422.
6. Mandell, LA, Wunderink, RG, Anzueto, A. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007; 44: S27-S72.
7. Niederman, MS, Mandell, LA, Anzueto, A. Guidelines for the management of adults with community acquired pneumonia: diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 2001; 163: 1730-1754.
8. Cheng, K, Zhou, S, Ma, J. Epidemiological characteristics of adult community-acquired pneumonia outpatient in Baoshan District of Shanghai. Clin Res 2009; 26: 1385-1387.
9. Song, JH, Oh, WS, Kang, CI. Epidemiology and clinical outcomes of community-acquired pneumonia in adult patients in Asian countries: a prospective study by the Asian network for surveillance of resistant pathogens. Int J Antimicrob Agents 2008; 31: 107-114.
10. Peto, L, Nadjm, B, Horby, P. The bacterial aetiology of adult community-acquired pneumonia in Asia: a systematic review. Trans R Soc Trop Med Hyg 2014; 108: 326-337.
11. Society of Respiratory Disease, Chinese Medical Association. Guidelines of Diagnosis and Treatment for Community-acquired Pneumonia in China adults (2016). Chin J Tuberculosis Respir Dis 2016; 39: 253-279. [in Chinese]
12. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing-Twenty Fourth Edition: Approved Standard M100-S24. CLSI, Wayne, PA, USA, 2014.
13. Peto, L, Nadjm, B, Horby, P. The bacterial aetiology of adult community-acquired pneumonia in Asia: a systematic review. Trans R Soc Trop Med Hyg 2014; 108: 326-337.
14. Gadsby, NJ, Russell, CD, McHugh, MP. Comprehensive molecular testing for respiratory pathogens in community-acquired pneumonia. Clin Infect Dis 2016; 62: 817-823.
15. Liu, YN, Chen, MJ, Zhao, TM A multicentre study on the pathogenic agents in 665 patients with community-acquired pneumonia in cities of China. Chin J Tuberc Respir Dis 2006; 29: 3-8.
16. Wen, YM. Modern medical microbiology[M]. Shanghai: Shanghai Medical University Press, 1999: pp.97−111.
17. Xie, BY, Mie, QR, Wang, J. Analysis of distribution of bacteria and drug resistance in elderly community-acquired pneumonia. Chinese Medical Record 2016; 17: 58-60.
18. Liu, XX, Liu, YQ, Yin, SF Drug resistance of pathogenic bacteria isolated from adult patients with community-acquired pneumonia in Tangshan. Chin J Nosocomiol 2014; 24: 562-564.
19. Freeman, JT, Rubin, J, McAuliffe, GN. Differences in risk-factor profiles between patients with ESBL-producing Escherichia coli and Klebsiella pneumoniae: a multicentre case-case comparison study. Antimicrob Resist Infect Control 2014; 3: 27.
20. Yang, Q, Yu, YS, Lin, J Distribution and antimicrobial resistance profile of common pathogens isolated from respiratory secretion in CHINET Antimicrobial Resistance Surveillance Program, 2005-2014. Chin J Infect Chemother 2016; 16: 541-550.
21. Gómez Rueda, V, Zuleta Tobón, JJ. Risk factors for infection with carbapenem-resistant Klebsiella pneumoniae: a case-case-control study. Colomb Med (Cali). 2014; 45: 54-60.
22. Baquero, F, Negri, MC, Morosini, MI. Antibiotic-selective environments. Clin Infect Dis. 1998; 27: S5-S11.
23. Jain, S, Self, WH, Wunderink, RG. Community-acquired pneumonia requiring hospitalization among U.S. adults. N Engl J Med 2015; 373: 415-422.
24. Chalmers, JD, Taylor, JK, Singanayagam, A. Epidemiology, antibiotic therapy, and clinical outcomes in health care associated pneumonia: a UK cohort study. Clin Infect Dis 2011; 53: 107-113.
25. Musher, DM, Roig, IL, Cazares, G. Can an etiologic agent be identified in adults who are hospitalized for community-acquired pneumonia: results of a one-year study. J Infect 2013; 67: 11-18.